Table 10.
Prevention and quality of care
| REGARDS reference—author |
Year | Topic |
|---|---|---|
| [178]—Brown et al. | 2014 | Prevalence of optimal risk factor goal |
| [179]— | Booth et al. | 2014 Ideal lifestyle factors and CHD risk |
| [183•]—Glasser et al. | 2008 | Aspirin use by race and geography |
| [186]—Cushman et al. | 2010 | Applying JUPITER and ATP III criteria for statin use |
| [187]—Fisher et al. | 2008 | Effect of aspirin and statin use on CRP |
| [190]—Colantonio et al. | 2014 | Contrasting cholesterol guidelines in CKD |
| [194]—Glasser et al. | 2010 | Association of statin use and cognitive performance |
| [199]—Gamboa et al. | 2014 | Statin use in the presence of CHD |
| [200]—Howard et al. | 2009 | Association between CHD risk scores and mortality |